Riskpilot← Back to searchSign inGet full accessBIOBANK AS
ASActiveOrg 987709324Holsetgata 22, 2317 HamarResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20058 employeeswww.biobank.no
Revenue 2024
NOK 14,6M
+5% vs 2023
EBITDA margin
4.1%
-73% vs 2023
Equity ratio
66.6%
Financial strength
Net profit 2024
NOK 687K
-54% vs 2023
| Revenue | NOK 14,6M | +5% |
| EBITDA | NOK 592K | -73% |
| Net profit | NOK 687K | -54% |
| Total assets | NOK 16,4M | +10% |
| Equity | NOK 10,9M | +7% |
| Employees | 8 | — |
Legal name
BIOBANK AS
Org number
987709324
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12. mai 2005
Share capital
NOK 300 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Utvikle en sikker og profesjonell lagring av biologiske prøver fra hyr og fisk
Address
Holsetgata 22, 2317 Hamar
Email
sigbjorn.gregusson
@biobank.no
Website
www.biobank.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 920 | 4 300 | 6 407 | 6 503 | 8 527 | 9 856 | 10 578 | 10 305 | 16 386 | 16 259 | 18 610 | 14 354 | 13 311 | 14 537 | 13 930 | 14 607 |
| Staff expenses | −1 971 | −1 982 | −2 120 | −2 095 | −2 292 | −2 710 | −3 540 | −3 630 | −4 756 | −5 366 | −5 971 | −6 122 | −5 529 | −6 295 | −5 527 | −6 901 |
| EBITDA | −1 242 | −863 | 47 | 102 | 1 235 | 1 407 | 1 256 | 1 172 | 3 209 | 2 869 | 3 279 | 1 480 | 1 846 | 1 024 | 2 178 | 592 |
| Depreciation & amort. | −142 | −147 | −163 | −142 | −156 | −141 | −245 | −425 | −868 | −1 072 | −1 096 | −998 | −911 | −690 | −413 | −93 |
| EBIT | −1 385 | −1 010 | −116 | −40 | 1 079 | 1 265 | 1 011 | 747 | 2 340 | 1 796 | 2 184 | 481 | 936 | 334 | 1 765 | 499 |
| Net financials | −51 | −61 | −70 | −72 | −89 | −101 | −56 | −17 | −75 | −35 | −34 | −68 | −4 | 37 | 167 | 382 |
| Profit before tax | −1 436 | −1 070 | −186 | −112 | 990 | 1 165 | 955 | 730 | 2 265 | 1 761 | 2 149 | 413 | 932 | 371 | 1 932 | 880 |
| Tax | −0 | −0 | −0 | −0 | −986 | 301 | 261 | 197 | 543 | 47 | 450 | 72 | 199 | 72 | 425 | 194 |
| Net profit | −1 436 | −1 070 | −186 | −112 | 1 976 | 864 | 694 | 533 | 1 722 | 1 714 | 1 700 | 342 | 733 | 300 | 1 507 | 687 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 579 | 2 976 | 3 107 | 3 306 | 5 291 | 5 990 | 6 601 | 7 329 | 9 253 | 10 851 | 13 124 | 13 679 | 14 901 | 14 479 | 14 911 | 16 378 |
| Equity | 1 109 | 39 | −147 | −260 | 1 717 | 2 581 | 3 275 | 3 808 | 5 530 | 5 647 | 7 347 | 7 688 | 8 421 | 8 721 | 10 228 | 10 914 |
| Long-term debt | 1 750 | 1 550 | 1 350 | 1 550 | 2 150 | 1 950 | 1 750 | 2 050 | 1 892 | 1 350 | 1 200 | 1 200 | 1 200 | 0 | 0 | 0 |
| Short-term debt | 719 | 1 387 | 1 905 | 2 016 | 1 424 | 1 459 | 1 576 | 1 471 | 1 832 | 2 043 | 2 469 | 2 421 | 2 614 | 2 496 | 2 199 | 2 811 |
| Total debt | 2 469 | 2 937 | 3 255 | 3 566 | 3 574 | 3 409 | 3 326 | 3 521 | 3 723 | 3 393 | 3 669 | 3 621 | 3 814 | 2 496 | 2 199 | 2 811 |
EBITDA margin
4.1%
This company
15.8%
Market median
-74% vs market
20092024
Equity ratio
66.6%
This company
38.2%
Market median
+74% vs market
20092024
Return on equity
6.3%
This company
18.4%
Market median
-66% vs market
20092024
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20092024
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
20092024
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SG Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
LB Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Geno Sa | Company | 33.3% | 33.3% | 2024 |
Norsvin Sa | Company | 33.3% | 33.3% | 2024 |
Aquagen As | Company | 33.3% | 33.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Norsvin Sa
BIOBANK AS Board members of BIOBANK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigbjørn Gregusson | Chief Executive Officer | 0 companies |
| Laila Bekk | Chief Executive Officer | 0 companies |
| Odd Magne Rødseth | Board of Directors | 0 companies |
| Kristin Malonæs | Board of Directors | 0 companies |
| Olav Eik-Nes | Chairman | 0 companies |